Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1979 Jan;69(1):47-52.
doi: 10.2105/ajph.69.1.47.

Effects of written drug information on patient knowledge and compliance: a literature review

Review

Effects of written drug information on patient knowledge and compliance: a literature review

L A Morris et al. Am J Public Health. 1979 Jan.

Abstract

The prospect of patient-oriented prescription drug labeling has focused increased attention on the effectiveness of written information for the consumer. Studies which have evaluated the effects of written prescription drug information in a patient population are reviewed. Several studies indicate that written information can be effective in improving patient compliance with regimens for antibiotic therapy. However, for drugs used on a long-term basis, written information as a sole intervention has not been shown to be sufficient for improving patient compliance. Patient knowledge of less commonly known information, such as precautions, side effects, or special directions is frequently improved by written information. Listing a drug's side effects has not been shown to increase the reported experience of side effects; however, one study suggests that patients may be more willing to report side effects to a health professional if they are listed in the written information. The trend for recent studies has been to focus on the "milieu" in which written information is provided or to systematically vary structural features of the information in order to improve the quality of drug communications.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Psychol Med. 1976 Nov;6(4):599-601 - PubMed
    1. Hosp Pharm. 1976 Mar;11(3):91-2, 95-6 - PubMed
    1. Drug Intell Clin Pharm. 1978 Mar;12(3):161, 163-8 - PubMed
    1. Drug Intell Clin Pharm. 1976 Aug;10(8):448-53 - PubMed
    1. J Am Pharm Assoc. 1976 Feb;16(2):74-6, 85 - PubMed

Substances

LinkOut - more resources